Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Enlivex Therapeutics Ltd

1BT
Current price
1.41 EUR 0 EUR (0.00%)
Last closed 1.59 USD
ISIN IL0011319527
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 26 521 790 USD
Yield for 12 month -14.67 %
1Y
3Y
5Y
10Y
15Y
1BT
21.11.2021 - 28.11.2021

Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra, which is in phase II clinical trial for the treatment of organ dysfunction caused by sepsis. The company also develops Allocetra for the treatment of moderate knee osteoarthritis and end-stage knee osteoarthritis which is in phase I/II clinical trial. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel. Address: 14 Einstein Street, Ness Ziona, Israel, 7403618

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9.5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-835 000 USD

Last Year

-777 000 USD

Current Quarter

-160 000 USD

Last Quarter

-188 000 USD

Key Figures 1BT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -17 893 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -27.46 %
PEG Ratio
Return On Equity TTM -61.17 %
Wall Street Target Price 9.5 USD
Revenue TTM
Book Value 1.37 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.18 USD
Diluted Eps TTM -1.18 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 1BT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 1BT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:8
Payout Ratio
Last Split Date 06.03.2019
Dividend Date 06.03.2019

Stock Valuation 1BT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -1.4854
Price Book MRQ 0.9286

Financials 1BT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 1BT

For 52 weeks

1.15 USD 4.59 USD
50 Day MA 1.32 USD
Shares Short Prior Month 84 617
200 Day MA 2.13 USD
Short Ratio 2.02
Shares Short 74 676
Short Percent 0.38 %